No analyst on staff
Nobody else is going to read the cap table footnotes. Conviction reads every page you upload and cites the page behind each factual claim.
For angel investors
An investment committee for investors who don't have one.
Most angels decide alone, or after a group call about a twelve-slide deck. Conviction has independent specialist reviewers read the materials, then gives you a cited recommendation and a list of questions for the founder before you wire money.
The problem
Where diligence usually breaks down.
Deals outside your expertise
Good deals turn up in unfamiliar sectors. Life sciences deals get scientific, clinical, regulatory, and IP reviewers. Software deals get product, security, and go-to-market reviewers.
Terms get skimmed
SAFEs and notes hold the terms that shape your return. The Financial reviewer looks at valuation, dilution, runway, and how much capital the company needs to reach its next milestone.
Enthusiasm is contagious
Founders are persuasive, and so are co-investors. Reviewers never see each other's reports, and a Devil's Advocate makes the strongest evidence-based case against investing.
Your committee
A committee matched to each deal.
Life Sciences · 7 reviewers
- Scientific Reviewer
- Whether the science or technology works: target biology for a drug, engineering and bench data for a device, analytical performance for a diagnostic.
- Clinical Development Reviewer
- Study design, endpoints, safety and efficacy signals, and whether the clinical plan can prove the product out.
- Regulatory Reviewer
- The FDA pathway and its precedent: IND/NDA/BLA, 510(k), De Novo, or PMA, or the IVD and lab-developed-test route.
- IP / Freedom-to-Operate Reviewer
- Patent estate, chain of title, licenses, regulatory exclusivity, and freedom to operate against third-party patents.
- Commercial / Market Reviewer
- Market size, standard of care, competition, pricing, reimbursement, and adoption.
- Financial / Venture Reviewer
- Valuation, dilution, burn and runway, and the capital needed to reach the next catalyst.
- Devil’s Advocate
- The strongest evidence-based case not to invest, focused on risks the other reviewers are likely to miss.
SaaS / Technology · 6 reviewers
- Product Reviewer
- Product-market fit, architecture, differentiation, and whether the moat is real.
- Security & Compliance Reviewer
- Security posture, compliance certifications such as SOC 2, past incidents, and regulatory exposure.
- Go-to-Market Reviewer
- Sales motion, CAC payback, pipeline quality, churn, and net revenue retention.
- Market Reviewer
- Addressable market, competitive landscape, pricing power, and switching costs.
- Financial / Venture Reviewer
- Valuation, dilution, burn and runway, unit economics, and the capital needed to reach the next milestone.
- Devil’s Advocate
- The strongest evidence-based case not to invest, focused on risks the other reviewers are likely to miss.
A typical angel workflow
Create a deal, choose the Life Sciences or SaaS / Technology committee, and upload what the founder sent: the deck, a one-pager, a financial model export, the cap table, the SAFE. Documents stay in your private workspace.
Run the committee. You get a Chair recommendation with a conviction score, cited bull and bear cases, key risks, each reviewer's report, and a prioritized list of diligence questions.
Take those questions into your next founder call, add whatever new materials come back, and run the committee again. Every run is saved as a point-in-time record, so you can see how the case changed. If you invest alongside others, you can share a read-only copy of the analysis with them. Your source documents stay private.
Built for confidential materials
Private by default. Disciplined by design.
Your workspace is isolated from every other organization. Factual claims must cite the source material, and assumptions and judgments are labeled as such, so evidence and opinion stay separate.
Read about security and data handling →Frequently asked questions
How do angel investors usually do due diligence?
Most look at the team, the market, the product, traction, and the terms, often with help from a group screening committee or a domain expert they know. Conviction gives that first pass some structure: each area gets an independent reviewer, and the gaps come back as questions for the founder. It doesn't replace reference calls or your own judgment.
Is Conviction free for angel investors?
You can start on the free plan without a credit card. It includes a limited number of deals, and you can email help@convictionic.com if you need more.
Who can see the documents I upload?
Only your workspace. Sharing a deal gives someone a read-only view of the analysis, not your source documents. When you choose a hosted AI model, the materials are sent to that provider for analysis. The security page has the details.
Free to start
Bring a deal. Leave with a more defensible decision.
Create a free workspace and run your first committee analysis in minutes. No credit card required.
Start free →Conviction is decision-support software, not investment, medical, or legal advice.